| 2007 JASN IMPACT FACTOR 7.111 | HOME AUTHOR INFO EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP | |||
| CURRENT ISSUE | ARCHIVES | JASN Express | ONLINE SUBMISSION | |
Journal of the American Society of Nephrology, Vol 6, 177-183, Copyright © 1995 by American Society of Nephrology
REGULAR ARTICLES |
WE Bloembergen, FK Port, EA Mauger and RA Wolfe
Department of Internal Medicine, School of Medicine, University of Michigan, Ann Arbor, USA.
Patients with ESRD treated with dialysis have a high mortality rate. Controversy exists as to whether this high mortality rate is affected by modality choice. The purpose of this epidemiologic study was to compare mortality in prevalent hemodialysis-treated (HD) and peritoneal dialysis-treated (PD) patients in a large national sample, adjusting for demographic characteristics. Data were obtained from the U.S. Renal Data System for patients prevalent on January 1 of the years 1987, 1988, and 1989, each with 1 yr of follow-up. Patients were censored at transplantation. Death rates per 100 patient years were compared between HD and PD, adjusting for age, race, gender, cause of ESRD (diabetes versus nondiabetes) and < 1 yr or > 1 yr of prior ESRD, by the use of Poisson regression. There were 42,372 deaths occurring over 170,700 patient years at risk. On average, prevalent patients treated with PD had a 19% higher adjusted mortality risk (relative risk (RR) = 1.19; P < 0.001) than did those treated with HD. This risk was found to be insignificant (P > 0.05) and small for ages < 55 and increasingly large and significant for ages > 55 yr. It was accentuated in diabetics (RR = 1.38; P < 0.001) but was also present in nondiabetics (RR = 1.11; P < 0.001). Although present in both males and females, this risk was accentuated in females (RR = 1.30 versus 1.11; both P < 0.001). In this national study of prevalent U.S. dialysis patients, treatment assignment to PD was associated with a 19% higher all-cause mortality rate than HD.(ABSTRACT TRUNCATED AT 250 WORDS)
This article has been cited by other articles:
![]() |
P. M. Just, F. Th. de Charro, E. A. Tschosik, L. L. Noe, S. K. Bhattacharyya, and M. C. Riella Reimbursement and economic factors influencing dialysis modality choice around the world Nephrol. Dial. Transplant., July 1, 2008; 23(7): 2365 - 2373. [Abstract] [Full Text] [PDF] |
||||
![]() |
O. Khawar, K. Kalantar-Zadeh, W. K. Lo, D. Johnson, and R. Mehrotra Is the Declining Use of Long-Term Peritoneal Dialysis Justified by Outcome Data? Clin. J. Am. Soc. Nephrol., November 1, 2007; 2(6): 1317 - 1328. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. de Jonge, B. Bammens, W. Lemahieu, B. D. Maes, and Y. Vanrenterghem Comparison of peritoneal dialysis and haemodialysis after renal transplant failure Nephrol. Dial. Transplant., June 1, 2006; 21(6): 1669 - 1674. [Abstract] [Full Text] [PDF] |
||||
![]() |
B. G. Jaar, J. Coresh, L. C. Plantinga, N. E. Fink, M. J. Klag, A. S. Levey, N. W. Levin, J. H. Sadler, A. Kliger, and N. R. Powe Comparing the Risk for Death with Peritoneal Dialysis and Hemodialysis in a National Cohort of Patients with Chronic Kidney Disease Ann Intern Med, August 2, 2005; 143(3): 174 - 183. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Schulman Mortality and Treatment Modality of End-Stage Renal Disease Ann Intern Med, August 2, 2005; 143(3): 229 - 231. [Full Text] [PDF] |
||||
![]() |
F. Termorshuizen, J. C. Korevaar, F. W. Dekker, J. G. van Manen, E. W. Boeschoten, and R. T. Krediet Hemodialysis and Peritoneal Dialysis: Comparison of Adjusted Mortality Rates According to the Duration of Dialysis: Analysis of the Netherlands Cooperative Study on the Adequacy of Dialysis 2 J. Am. Soc. Nephrol., November 1, 2003; 14(11): 2851 - 2860. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. C. Winkelmayer, R. J. Glynn, M. A. Mittleman, R. Levin, J. S. Pliskin, and J. Avorn Comparing Mortality of Elderly Patients on Hemodialysis versus Peritoneal Dialysis: A Propensity Score Approach J. Am. Soc. Nephrol., September 1, 2002; 13(9): 2353 - 2362. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. G. Kutner, R. Zhang, W. M. McClellan, and S. A. Cole Psychosocial predictors of non-compliance in haemodialysis and peritoneal dialysis patients Nephrol. Dial. Transplant., January 1, 2002; 17(1): 93 - 99. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. G. Heaf, H. Lokkegaard, and M. Madsen Initial survival advantage of peritoneal dialysis relative to haemodialysis Nephrol. Dial. Transplant., January 1, 2002; 17(1): 112 - 117. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. Keshaviah, A. J. Collins, J. Z. Ma, D. N. Churchill, and K. E. Thorpe Survival Comparison between Hemodialysis and Peritoneal Dialysis Based on Matched Doses of Delivered Therapy J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S48 - 52. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. Gokal Peritoneal Dialysis in the 21st Century: An Analysis of Current Problems and Future Developments J. Am. Soc. Nephrol., January 1, 2002; 13(90001): S104 - 115. [Full Text] [PDF] |
||||
![]() |
L. M. MOIST, F. K. PORT, S. M. ORZOL, E. W. YOUNG, T. OSTBYE, R. A. WOLFE, T. HULBERT-SHEARON, C. A. JONES, and W. E. BLOEMBERGEN Predictors of Loss of Residual Renal Function among New Dialysis Patients J. Am. Soc. Nephrol., March 1, 2000; 11(3): 556 - 564. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. VAN BIESEN, R. C. VANHOLDER, N. VEYS, A. DHONDT, and N. H. LAMEIRE An Evaluation of an Integrative Care Approach for End-Stage Renal Disease Patients J. Am. Soc. Nephrol., January 1, 2000; 11(1): 116 - 125. [Abstract] [Full Text] |
||||
![]() |
D. E. SCHAUBEL and S. S. A. FENTON Trends in Mortality on Peritoneal Dialysis: Canada,1981-1997 J. Am. Soc. Nephrol., January 1, 2000; 11(1): 126 - 133. [Abstract] [Full Text] |
||||
![]() |
C.-G. Elinder, E. Jones, J. D. Briggs, O. Mehls, S. Mendel, G. Piccoli, S. P. A. Rigden, J. P. d. Santos, K. Simpson, D. Tsakiris, et al. Improved survival in renal replacement therapy in Europe between 1975 and 1992 : An ERA-EDTA Registry study Nephrol. Dial. Transplant., October 1, 1999; 14(10): 2351 - 2356. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. ANDO, T. SANAKA, and H. NIHEI Eicosapentanoic Acid Reduces Plasma Levels of Remnant Lipoproteins and Prevents in Vivo Peroxidation of LDL in Dialysis Patients J. Am. Soc. Nephrol., October 1, 1999; 10(10): 2177 - 2184. [Abstract] [Full Text] |
||||
![]() |
E. B. Bass, M. W. Jenckes, N. E. Fink, K. A. Cagney, A. W. Wu, J. H. Sadler, K. B. Meyer, Andrews. Levey, and N. R. Powe Use of Focus Groups to Identify Concerns about Dialysis Med Decis Making, August 1, 1999; 19(3): 287 - 295. [Abstract] [PDF] |
||||
![]() |
E. F. VONESH and J. MORAN Mortality in End-Stage Renal Disease: A Reassessment of Differencesbetween Patients Treated with Hemodialysis and Peritoneal Dialysis J. Am. Soc. Nephrol., February 1, 1999; 10(2): 354 - 365. [Abstract] [Full Text] |
||||
![]() |
R. A. WARD and M. E. BRIER Retrospective Analyses of Large Medical Databases: What Do They TellUs? J. Am. Soc. Nephrol., February 1, 1999; 10(2): 429 - 432. [Full Text] |
||||
![]() |
S. Pastan and J. Bailey Dialysis Therapy N. Engl. J. Med., May 14, 1998; 338(20): 1428 - 1437. [Full Text] [PDF] |
||||
|
HOME
CURRENT ISSUE
ARCHIVES
JASN Express
ONLINE SUBMISSION
AUTHOR INFO
EDITORIAL BOARD SUBSCRIBE FEEDBACK ALERTS HELP |
Copyright © 2008 by the American Society of Nephrology. Online ISSN: 1533-3450 Print ISSN: 1046-6673